Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
INC Research Holdings Inc
INCR | US
0.77
USD0.00
0.40%
INCR | US
About INC Research Holdings Inc
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/06/2024
As of date
17/04/2026
Close
0.77
Open
0.78
High
0.79
Low
0.76
InterCure Ltd. together with its subsidiaries engages in the research cultivation production and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya Israel.
View LessINCR | US
Risk
31.7
Sharpe
-0.98
Luna's Score
51/100
Recommendation
Hold
Luna says (INCR | US)
What's Working
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
31.0%1 month
31.7%3 months
36.6%6 months
51.0%Returns
Fundamental Ratios
PE
-
Fwd. PE
6.94
Price to book
0.65
Debt to equity
0.29
Debt to assets
0.18
Ent. to EBITDA
5.29
Ent. to rev.
1.58
PEG
-
Other Fundamentals
EBITDA
2.95M
MarketCap
35.24M
MarketCap(USD)
35.24M
Div. yield
-
Op. margin
8.20
Erngs. growth
-84.70
Rev. growth
-38.60
Ret. on equity
-13.61
Short ratio
0.82
Short perc.
0.08
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.07
Range1M
0.08
Range3M
0.26
Volumes: Market Activity
Rel. volume
2.24
Price X volume
37.88K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 5.29 | - | Cheaper |
| Ent. to Revenue | 1.58 | - | Cheaper |
| PE Ratio | - | 30.05 | - |
| Price to Book | 0.65 | 13.15 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 36.56 | - | Lower Risk |
| Debt to Equity | 0.29 | -1.88 | Expensive |
| Debt to Assets | 0.18 | 0.48 | Cheaper |
| Market Cap | 35.24M | - | Emerging |
